Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
DLPA | NSE | INR | Real-time | |
DLPA | Derived | INR | Real-time | |
DLPAc1:NS | NSE | INR | Delayed | |
DLPA | BSE | INR | Delayed |
Dr. Lal PathLabs Limited reported earnings results for the second quarter and six months ended September 30, 2024. For the second quarter, the company reported sales was INR 6,602 million compared to INR 6,013 million a year ago. Revenue was INR 6,821 million compared to INR 6,194 million a year ago. Net income was INR 1,292 million compared to INR 1,093 million a year ago. Basic earnings per share from continuing operations was INR 15.52 compared to INR 13.16 a year ago. Diluted earnings per share from continuing operations was INR 15.48 compared to INR 13.12 a year ago. For the six months, sales was INR 12,621 million compared to INR 11,423 million a year ago. Revenue was INR 13,046 million compared to INR 11,748 million a year ago. Net income was INR 2,356 million compared to INR 1,919 million a year ago. Basic earnings per share from continuing operations was INR 28.3 compared to INR 23.11 a year ago. Diluted earnings per share from continuing operations was INR 26.24 compared to INR 23.05 a year ago.
Period Ending: | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
---|---|---|---|---|
Total Revenue | 6602 | 6019 | 5454.41 | 5389 |
Gross Profit | 4089 | 3659 | 2594.3 | 3229 |
Operating Income | 1672 | 1353 | 1105.48 | 1046 |
Net Income | 1292 | 1064 | 845.35 | 813 |
Period Ending: | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
---|---|---|---|---|
Total Assets | 25975 | 24559.63 | ||
Total Liabilities | 5623 | 5705.99 | ||
Total Equity | 20352 | 18853.64 |
Period Ending: | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | ||||
Cash From Investing Activities | ||||
Cash From Financing Activities | ||||
Net Change in Cash |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review